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I P845 1 Evaluation of Pentoxifylline Treatment of Sepsis 
of Premature Infants in Double Blind 
Randomized, Prospective Study 
R. Lauterbach, M. Zembala, D. Pawlik, D. Kowalczyk, 
W. Ksycitklu, E. Helwich. Dpf  ofNeona~ology;Jnian Univmity 
Medical College, Cramw, Poland, Dpt o j  Clinical Immunology; 
Jagiellonian University Medical College, Cracow, Poland, Dpt of 
Neonatology Mother-Children Hospital, t 6 d 2 ,  Poland 
Objectives: 1-to evaluate the influence of pentoxifjUine (PTXF) 
treatment on m o d t y  rate in the course of sepsis; 2-to estimate the 
elevation of tumor necrosis-alpha (TNF) interleukine-1 (IL-1) and 
interleukine-6 (IL-6) in relation to h c a l  symptoms; 3- to compare 
the plasma TNF, IL-1 and IL-6 level between the idants. 
Methods: Prematurely delivered infants with diagnosis of sep- 
sis were randomly assigned to receive PTXF (pod group) or saline 
(placebo group) by means ofpermuted block randomization scheme. 
The randomization was calculated for a sample sue of 100 infants 
(two groups of 50 subjects). These two groups were comparable 
according to birth weight, gestational age and Apgarscore. Both 
groups were subjected to the same conventional therapy. The PTXF 
(Pentiline, Krka, Slovenia) was given intravenously in a dose of 5 
mg/kg per h for 6 h. The first infusion of PTXF or s h e  started 
about 30 min. before antibiotics were adnunistered. Identical in- 
fusions were repeated on the following five days of theram. TNF, 
IL-1 and IL-6 were determined by immuno-enzymetric tests (Elisa, 
Medgenix, Fleurus, Bebum). Blood samples were collected fkm 
newborns: on the lst, 3rd and 6th day of treatment before and after 
the PTXF or s h e  tnfusion. 
Results: There were a statistically siguficantly lower plasma levels 
of TNF and IL-6 in the ptdgroup on the h r d  day of therapy when 
compared to the results obtained in placebo group (TNF-mean: 94 
pg/ml, vs 347 pg/ml; IL-6-mean: 27.12 pg/ml vs 168.3 pg/ml); 2 
of 8 dants with signs of shock in placebo group survived, whereas 
only 1 of 6 respective infants in podgroup died (p < 0.03). 
Conclusions: PTXF limits synthesis of TNF and IL-6 what may 
have beneficial inAuence on the prognosis in sepsis of premature 
infants. 
Ip846j Thyroid Functions in Patients With Sepsis 
B. Aygen, M. Inan, M. Do&ay, E Keleshur. Emdyes Uniuersity, 
Kayseri, Turkey 
Objectives: To evaluate thyroid functions in patients with sepsis. 
Methods: This study included 49 patients over 17 year old and 
diagnosed as sepsis, sepsis syndrome or septic shock. Within 24 hour 
on the dugnosis of sepsis, thyroid function tests were performed. 
The tests were repeated in the recovered patients at 14th day. 
Results: Etiological agent was isolated in 35 (71.4%) patients 
(57.1% gram negative bacteria, 34.3% gram positive bacteria and 
8.6% polymicrobial). Fourteen (28.6%) patients died. Sepsis score 
was sigruficantly higher in the patients who died (18.6 f 4.7) than in 
the patients who recovered (14.5 f 4.1) (p < 0.01). Mean serumeee 
triiodothymmne (ST3) level was 0.72 f 0.75 pg/ml, mean serum 
fkee thyroxine (ST4) level was 0.83 f 0.41 ng/dl, mean serum total 
triiodothyronine (TT3) level was 35.44 f 22.87 ng/dl and mean 
serum total thyroxine (TT4) l e d  was 4.95 f 1.95 f ig/dl in the 
patients who recovered and mean serum ST3 level was 0.33 5 0.37 
pg/ml, mean ST4 level was 0.42 f 0.34 ng/dl, mean TT3 level 
was 19.18 f 12.04 ng/dl and mean TT4 level was 2.69 f 2.04 
wg/dl in the patients who died. The Merence between two groups 
was sigNficant. Mean thyroid stimulating hormone (TSH) level was 
1.59 f 1.54 plU/dl in the patients who recovered and 1.78 f 3.07 
fiIU/dl in the patients who died. Within 14th day on the diagnosis 
of sepsis, thyroid functions tests was sigmfkantly improved in the 
patients who recovered. 
Conclusion: This study shows that there is a strong correlation 
between mortality and the decrease in serum TT4 and euthyroid 
sick syndrome developed in the patients with sepsis. 
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Jp847j TNF-a Secretion by Human Monocytes 
Stimulated with Yeast Form of Candida albicans: 
Influence of Serum Opsonins 
M.C. Gheui, G. Raponi, T. Delli Castelli, C. Mancini. I Clinical 
Microbioloa, Univenity "La Sapienza", Rome, Italy 
Objectives: This study was designed to investigate the role ofserum 
opsonins in the mechanism of production of TNF-a by human 
monocytes upon stimulation with yeast form of C. albicans. 
Methods: Heat killed C. albicans wild strain was opsonized with 
medium only, fresh or heat-inactivated human pooled serum (HPS), 
C1 and C3 depleted serum, fraction of HPS concentrated at dd€erent 
molecular weight and HPS supplemented with either 5 or 25 mg/ml 
of D-mannose. 
Results: Non-opsonized C. albicans induced the production of 
low amount ofcytokines. Opsonization of C. albicans in 10% HPS 
led to a significant enhancement of TNF-a secretion. Heat inactiva- 
tion of serum as well as C1 and C3 serum depletion, did not reduce 
cytokine release. The amount of TNF-a release after opsonization 
with serum fraction, was SigNficantly higher with serum filtrates 
having a Molecular Weight cut-off above 50.000 Da. The presence 
of D-mannose enriched HPS reduced in all instances the release of 
TNF-a from monocytes. 
Conclusions: C. albicans induces the secretion of TNF-a by hu- 
man monocytes. The release of TNF-a is enhanced by the presence 
of heat stable serum factors, but not by the presence of heat labile 
serum opsonins such as complement. Among serum opsonins, man- 
nan binding protein seem to be involved in the serum mediated 
enhancement of TNF-a release. 
Jps48/ G-CSF (Filgrastirn) Treatment of Volunteers 
Increases Blood Bactericidal Activity but 
Decreases Inflammatory Responses 
T. Hartung, E Brockhaus, A. Wendel. University ofKonstunz, 
Germany 
Objectives: To determine the immunomodulation caused by treat- 
ment of healthy volunteers with G-CSE 
Methods: Two groups of six male healthy volunteers (70-90 kg) 
were double-blindly injected S.C. 300 fig G-CSF (Figrastim, Am- 
gen) or solvent placebo for 12d. Blood was withdrawn on days 1 
(pretreatment), 2, 3, 5, 8 and 12 to assess whole blood bactericidal 
activity to Salmonelta abortus equi as well as blood cytokine response 
to S. abortus equi endotoxin (LPS). 
Resulw Treatment with G-CSF was well tolerated by the vol- 
unteers. Neutrophilic granulocyte counts increased ten-fold in the 
treaunent group. An initial amount of lo5 CFU Salmonella added 
to 20% whole blood from untreated donors expanded to 10' CFU 
within 24 h. In contrast, in blood fkm G-CSF treated subjects, only 
lo4 to lo5 CFU were found at any day of study. 
When in a sirmlar approach, whole blood was incubated in the 
presence of LPS, the release of the pro-inflammatory cytokines 
TNFu and IFNy was sigdcantly reduced in the G-CSF treat- 
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ment group: IFNy release in response to LPS was reduced by 70% 
h m  day 2 to 12. TNF formation by monocytes, however, became 
more pronounced during the treatment come (30% at day 2, 80% 
at day 12). 
Conclusions: G-CSF is characterized by anti-infectious as well as 
anti-inflammatory properties without evidence of tachyphylaxis thus 
allowing sustained treatment. Thls unique combination of pharma- 
codynamic properties seem suitable for experimental therapies for 
non-neutmpenic infection, sepsis prophybs and HIV. 
lp8491 Interleukin 6 Activity in Children with Mumps 
Meningitis 
L. Szenborn ' , M. Weiss ', D. Adam ', 2. Rudkowski I .  ' Clinicfor 
Infertious Dueases of Children Wrochtq Poland, 'Dr v. Haunersches 
Kinderspital Miinchen, Germany 
Objectives: Interleukin 6 (IL-6) is multipotent cytokine that acts in 
a network of factors directing the inflammatory reaction of puru- 
lent and aseptic meningitis. Concentrations of IL-6 in cerebrospinal 
fluid (CSF) and serum of children with mumps meningitis were 
determined and correlations were sought with other indices of in- 
flammation. 
Methods: Twenty patients of ages between 1.5 to 10 years were 
studied. In all cases mumps-specific serum IgM and IgG has been 
found by using immunofluorescence tests (BIOS). We used a mono- 
c l o d  antibody ELISA (Immunotech) to test IL-6 in CSF and serum 
at admission and 7-10 days later. 
Results: Increased levels of IL-6 were detected in the CSF of 
all patients. At admission mean values were 429.88 pg/ml (range 
32.57-1437.17, median 218.53 pg/ml) and 7-10 days later 2.88 
pg/ml (range 1.65-6.08, median 2.74 pg/ml). On the contrary 11-6 
in serum was detected at mean concentration 300 pg/ml (range 
0.0-1663.9, median 28.6 pg/ml) at admission and at mean concen- 
tration 332 pg/ml (range C-1611.0. median 7.38 pg /d )  after 7-10 
days. There were no correlations between IL 6 in CSF and in serum. 
Concentration of CSF IL-6 correlated positive with polymorphonu- 
clear cells both in CSF (r = 0.47, p. = 0.037) and in blood (r = 0.58, 
p. = 0.007), and also with CSF protein concentration (r = 0.46, p = 
0.027). 
Conclusions: These results showed that in patients with mumps 
meningitis the IL-6 is differently released in the intrathecal space 
and in serum. IL-6 plays an important role in the pathogenesis and 
inflammatory response in mumps. 
I P850 I Role of Cytokines in Patients with Brucetlosis 
A. Cascio ', P. Iona', S .  Giordano ', E Gervasi'. 'Istituto di Patologia 
Infettiva e Krologia, University of Palermq Italy, 'Laboratorio di Analisi, 
Ospedale "G. Di Cristina", Palermo, Italy 
Brucella is a facultative intracellular pathogen that tends to persist 
within resident tissue macrophages and is elmmated by immuno- 
logically activated macrophages. In fact, resistance to intracellular 
bacteria depends on successful interaction between specifically sensi- 
tized T lymphocytes and macmphages. A poor macrophage response 
may cause less immunologic response in brucellosis. 
Objectives: The aim of this work is to evaluate the in vivo role 
of IL-10, TNF-cz, IL-6, and IL-12 in patients with brucellosis, to 
correlate their levels with clinical and analyacal parameters of dis- 
eases severity and to realize a potential polarization to THl  or TH2 
immune response. 
Methods: We d y z e d  data derived fiom 39 patients with acute 
brucellosis, of these 21 were children (13 males), of a median age 
of 6.8 years (range, 2 to 14 years) and 18 adults (9 males) of a 
me& age of 38 years (range, 15 to 75 years). The diagnosis was 
estabdished by the serum agglutination test. Serum specimen were 
obtained before the start of treatment and 2 months after the end of 
theiapy. IL-10, TNF-a, IL-6, and IL-12 levels were determined by 
commercial ELISAs (R&D Systems, Space Import-Export Milano). 
Results: Before treatment the majority of patients had increased 
levels of IL-10, TNF-ct and IL-6, whde after recovery only increased 
levels of IL-12 were detected. Not statistically sipficative Merences 
of the levels of the cytokines considered were observed among adults 
and children. 
Conclusions: The results confirm that during the active phase of 
the disease a marked predominance of TH2 reponse, while after the 
recovery a TH1 response is prevalent. 
Cytokine Regulation of lmmunogenesis at  
Brucellosis 
V Kozlovsky. Research Institutefor Plague Control, Rostov on Don, 
Russia 
Objectives: The lymphokmes synthesis by cells of the immune sys- 
tem of mice immunized with M e d  microbial cells of Brucella abortus 
19-BA was investigated. 
Methods: A research of the helper effect of induced im- 
munoregulatory cells conducted in the system of adoptive trans- 
fer. IL-Zactivity determined on increase of the proliferation of 
Con A-activated blasts. IL-4- and IL-5-activity determined on the 
comitogenic effect in respect to the proliferation of a cleared pop- 
ulation of B-lymphocytes in conditions of their stimulation by 
rabbit anti-mouse immunoglobulins or s u b o p d  doze of dex- 
tran-sulphate accordmgly. 
Results: The transfer of cleared T-cells &m immunized to intact 
mice provides expressed helper effect in respect to immunization 
with an heterologous antigen. In the culture supernatants of spleno- 
cytes of the immunized mice as at primary, and secondary immune 
response a high degree of activity IL-2 is determined. At the primary 
stimulation with B.  abortus 19-BA the defined level of IL-Zactivity 
in culture supernatants is much higher, than at the secondary im- 
mune response of the primed cells. The marked phenomenon bears 
witness to the much higher consumption level of IL-2 by B .  abortus 
19-BA LPS-activated B-cells in matching with intact lymphocytes. 
The research of comitogenic activity of supernatants in other model 
system with use of a cleared B-lymphocytes population of the intact 
mice has shown increase of production of IL-4 and IL-5. 
Conclusion: B .  abortus 19-BA antigens stipulate the amplifica- 
tion of proliferative and synthetic activity of the immunocytes. The 
implementation of the helper effect of primed T-cells is connected 
with activation of synthesis at least three mediators: IL-2, IL-4 and 
IL-5. Probably, the redundant activity of these lymphokines is the 
reason of expressed allergization and gravity of brucellosis. 
lp8521 Cytokines in Cerebrospinal Fluid (CSF) and 
Serum in Patients with Bacterial Meningitis 
W Prryjalkowski', D. Lipowski', Z .  Lewandowski', 
R. Nowicka ', J. Janeczko '. 'Institute of Infectious and Parasitic 
Diseases, Poland, 'Department of Epidemiology; Warsaw Medial School, 
Poland 
Cytokines play an important role in inhnmatory response. We are 
interested of its intrathecal and serum levels to gain insight into 
pathogenesis of bacterial meningitis. 
Material and Methods: The CSF and serum levels of interleukm 
a ) - 1 ,  tumor necrosis factor4 (TNFu), and IL-6 of 12 patients 
with bacterial meningitis treated in our ICU were analyzed simulta- 
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neously. Assays were repeated four times: on the first, third, fifth day 
and two weeks after onset. The ELISA method was employed. The 
nonparametric statistics was used according to nonnormal distribu- 
tions (Wilcoxon or Spearman test). 
Results: The CSF concentrations of IL-1, IL-6 and TNFa in the 
first examinations were high and for majority of patients higher then 
in serum. During the treatment umform decrease of CSF IL-1, IL-6 
and TNFa levels was observed. In serum the sigruficant decrease of 
IL-6 and TNFa levels were noticed only during the first two days, 
after that the values didn't change sigmficantly. In CSF we observed 
correlation between concentration of IL-1 and TNFa (r = 0.80, p 
< 0.002), but there were not correlations between CSF and serum 
concentrations of IL-I, IL-6 and TNF a, behind the correlation 
between CSF and serum IL-6 concentration (r = 0.90, p -= 0.0003). 
Conclusions: In bacterial meningitis we observed acute phase 
response in CSF expressed by high levels of IL-1, IL-6 and TNFa 
followed by gradual declining concentrations. Our results show com- 
partmentalisation and dynamics of the inflammatory response. 
[ E l  Neutrophilokine-Inducing Activity of Yersinia 
Pestis Lipopolysaccharide and Its Detoxified 
Derivatives 
G. Vasilieva, I. Bespalova, L. Verkina, A. Kiseleva, S. Tjukavkina. 
Research Institute for Plague Control, Rostov-on-Don, Russia 
Objectives: of the study was to estimate iduence of the 
Ersinia pestis lipopolysaccharide (LPS) detodcation on its neu- 
trophilokine-inducing activity. 
Methods: The detoxified derivatives-deacylated LPS (DLPS) 
and dephosphorylated LPS (LPSP-) were obtained respectively by 
0-deacylation and dephosphorylation of initial LPS preparation LPS. 
DLPS and LPSP- were used as inductors of neutrophilokines that 
mediate macrophage-neutrophil cooperation. Neutrophdohes syn- 
tesized by intact and immune peritoneal neutrophiles were obtained. 
The influence of the obtained cytokines on differentiation of mono- 
cytes to macrophages, their killing and chemotactic activities, f?e- 
quency of phagosome-lysosome fusion in macrophages and distribu- 
tion of macrophage subpopulations in the total pool of these cells 
was investigated. 
Results: The study has shown that all obtained neutrophilokines, 
especially those produced by immune neutrophiles, promote the 
ckfferentiation of monocytes to macrophages, enhance the &g 
and chemotactic activities of macrophages, increase the kequency of 
phagosome-lysosome fusion in these cells and induce the redistri- 
bution of the macrophage subpopulations in the total pool. Neu- 
trophilokines induced by the detoxified derivatives of LPS, especially 
DLPS, have been shown the most activity. 
Conclusion: These data have shown that the k: pestis LPS detox- 
hcation, especially by the method of deacylation, does not lead to 
decrease in biological, in pxticular neutrophilokine-inducing activ- 
ity of these preparations, but actually even increases it. Our results 
suggest the importance of comprehensive study of I! pestis DLPS as 
a potencial component of new prophylactic preparations. 
lp854/ Impact of Iron Chelation Therapy on Cellular 
G. Weiss ' , EE. Thuma ', M. Herold ', E.R. Werner', 
VR. Gordeuk 3.  'Dept .  of Internal Medicine, Univ. Hospital, Innsbmck, 
Austria, 'Univ. ofHershq: PA, USA, 'G. Washington Uniu. Medical 
Center, D.C., USA 
Objectives: Perturbations of cellular iron homeostasis strongly d e c t  
cellular immune effector function via iron mehated regulation of cy- 
Immune Effector Function in Cerebral Malaria 
tokine activities (such as interferon-gamma) and macrophage medi- 
ated cytotoxicity. Most recently, we could idenhfy an auto-regulatory 
feedback mechanisms between posttranscriptional regulation of iron 
metabolism and cellular immune effector function of macrophages via 
the formation of NO by which activated macrophages are enabled to 
lmk maintenance of cellular iron homeostasis with optimal formation 
of NO for host defence. Recently, iron chelation therapy has been 
found to exert beneficd effects towards coma duration, parasite clear- 
ance and overall s u M d  in children with cerebral malaria. 
Methods: To determine whether these effects could be due in 
part to modulation of the cellular immune response and nitric oxide 
(NO) formation, we measured serum concentrations of the stable 
endproducts of NO, nitrite and nitrate (N02-/NOse), IL-4, IL-6, 
IL-10 and neopterin in 39 Zambian children with cerebral malaria 
enrolled in a placebo-controlled trial of desferrixamine B (dfo) in 
addition to quinine. 
Results: Mean concentrations of N02-/N03- increased signif- 
icantly over three days in children receiving dfo plus quinine, but 
not in those given placebo and quinine. Neopterin levels declined 
sigruficantly with placebo but not with dfo. IL-4 levels increased 
progressively in the placebo group and ultimatively decreased in 
the dfo group but the trend was not statistically significant. IL-6 
and IL-10 levels were elevated initially and decreased sigtllficantly in 
both groups over three days, and the effect was more pronounced in 
children receiving dfo. 
Conclusion: Our data are consistent with the hypothesis that iron 
chelation therapy in children with cerebral malaria strengthens TH-1 
mediated immune effector function involving increased production 
of NO by macrophages. 
I P855 I Nitric Oxide Response of Mouse Macrophages 
H. Baskin ' , N. Cakit '. 'Ministry $Health, Regional Institute of 
Hygiene, h i r ,  Turkey, ' 9  Eyliil University Hospital, Department o j  
MicrobioloB, fzmir, Turkey 
Objectives: To determine the nitric oxide (NO) response of mouse 
peritoneal macrophages against an inmcellular pathogen (Salmonella 
typhimurium). 
Methods: After establishment cultures h m  inbred, female 
BALB's mice. macrophages were incubated overnight with 5% C02. 
Then selected cultures were incubated with non-mutant, human 
isolated Salmonella typhimurium (3 x lo8 bacteria/ml), in its live and 
dead (by heating 30 minutes in 56OC water bath) forms for 30 min- 
utes in 5% COz. At the end of incubation, all cultures were washed 
3 times with 200 m g / d  gentamycin in RPMI-1640, then all cul- 
tures were incubated for 24 hours in control; deadllive bacteria; 
N-nitro-L-arginine methyl ester (L-NAME); and L-arginine groups 
and/or in combinations. After 24 hours, nitrite amountS of culture 
supernatants were determined with Griess reagent at 550 nm. Two 
fold dilutions of sodium nitric were used to generate a standard 
curve. 
Results: Macrophages incubated with live Salmonella typhimurium 
were produced a high nitrite response of 26 f 1.2 mmol (control: 1 
f 0.2 mmol) whereas inhibited with L-NAME (14 k 0.5 mmol) and 
increased with L-arginine addition to L-NAME (19 f 0.4 mmol). 
In dead bacteria groups (contro1:l 0.3 mmol) nitrite responses 
were sigmficantly low in bacteria; bacteria + L-NAME; bacteria + 
L-NAME + L-arginine groups (4.5 f 0.2; 2.8 f 0.1; 3.2 f 0.1 
mmol) respectively. 
Conclusion: NO response is sigruficantly high in macrophages 
against live Salmonella typhimuriurn as an intracellular pathogen. 
We believe that in future studies on pathogenesis of intracellular 
pathogens, N O  response mechanism($ and perhaps therapeutic ef- 
fect(s) would be interesting and important topics. 
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I P856 I Lysopaf and Inflammatory Neuronal Diseases 
R.M. Korth. Forschung in der Allgemeinmedizin (FDA)),  Palesm’mh. 
7A, Munich, Germany, INSERM U 200, Clamart, France 
Objectives: The etherphospholipid lysopaf was investigated in the 
cerebrospinal fluid (CSF) of patients h m  the Psychatric Hospital of 
the L u d w i g - M d a n s  University, Munich. 
Methods: Lysopaf and lysopaf bindmg were measured as de- 
scribed (Polonsky et al., 1980; Korth US Patent 5,346,894). 
Results: Lysopafwas detected in the CSF (500 11) Erom 48 psy- 
chiatric patients. 5 patients had inflammatory symptoms. A patient 
with encephaktis showed 20 ng lysopaf and 299 ng albumin, a pa- 
tient with inflammatory brain stem Symptoms had 5.0 ng lysopafand 
139 ng albumin, a patient with an unclear virus disease showed 4.4 
ng lysopaf and 83 ng albumin and a patient with multiple sclerosis 
showed 6.3 and 8.5 ng lysopafwith 139 and 71 ng albumin. Three 
patients without symptoms showed 2.9 f 1 ng lysopafwith 125 f 
4 ng albumin (fl S.D). 
Novel [3H]lysopafbindmg sites on neutrophils Erom healthy male 
volunteers showed a KD value of 9.2 nM. The ether group was 
upregulatory as unlabeled lysopaf or paf (5 nM) but not lysophos- 
phatidylchohe sigtllfcantly increased [3H]pafbinding (p < 0,001). 
PMA (1 nM) also upregulated [3H]pafbinding. 
Conclusion: Patients with inckcated inflammatory cerebral &- 
eases showed elevated CSF levels of lysopaf. An enhanced activity 
of phospholipases A2 during inflammatory neuronal disorders could 
trigger the production of upregulatory lysopaf. 
I P857 I Serum Interferon-7 (IFNy) and Interleukin 10 
(11-10) in Acute Cytomegalovirus Infection 
A. Szkaradkiewicz, J. Bogaczykka-Staniewicz, K.M. Lamperska. 
Karol Marcinkowski University $Medical Sciences in PozmA, Poland 
Cytomegalovirus (CMV) infection is reported to cause transient im- 
munosuppression in man. Our study aimed at finding out whether 
acute CMV infection in children is associated with disturbed serum 
IFN-y and IL-10 levels. 
The studies were performed on 15 patients, aging 10-16 years, 
manifesbng c h c a l  symptoms of acute viral infection and carry- 
ing serologically demonstrable IgM-anti-CMV antibodies (VIDAS 
CMV I@, bioMeriew). Cytokine levels were established in serum 
using Quantikinh“ human IFN-y immunoassay (R and D Systems) 
for IFN-y and Endogen human IL-10 ELSA for IL-10. In all ex- 
amined children of the group IL-10 level was 68.2 f 12.2 p g / d  and 
ckd not signtftcantly difLer h m  values obtained in the control group 
of healthy children (p > 0.05). On the other hand, serum IFN-y 
was below the detection level in 14 patients with acute CMV infec- 
tion and in a single case where it was detected it corresponded to 
the control level. 
The results inckcate that acute CMV infection is accompanied 
by a selectively decreased secretory activity of Thl lymphocytes, as 
expressed in the absence of IFN-y response. 
P858a I Interferon Status during Antigen-Induced 
Arthritis 
R.Y. Arinenko, VB. Anikin, M.G. Romantsov. Inzuenza Research 
Institute, St-Petersbuq, Russia 
Objectives: High lev& of interferon-y (IF-y) is known to inhibit 
the growth of C. harhomatis, but low level - to induce the develop- 
ment of morphologically abnormal intracellular forms because of in- 
dolamine-2,3-dioxygenase induction and qptophade pool decrease. 
It was the cause of our study of the importance of the interferon sta- 
tus (IFS) for diagnostic and treatment of antigen-induced arthritis 
Methods: IFS (i.e. general serum IF (sIF) content, the level of 
induced production of IF-a/B and IF-y (induction of IF-a/B, -y ) )  
of 25 chronic chlamidd AIA patients was tested by bioassay. 
Results: All the patients were noticed to have the increased sIF 
up to 23.3 f 4.5 IU/ml (vs. 4.5 f 2.8 IU/ml of normal, p < 0.05) 
and signhcant IF-y induction decrease (up to 22.0 f 1.7% ofnor- 
mal, p < 0.05). After combined course of surnamed and cycloferon 
(low-molecular IF inducer) we’ve got the remission of 18 patients 
(normalization of acute-phase indices, increase of IF-y induction up 
to 47.2 f 4.9% of normal, p < 0.01). 18 patients had C. trachomatis 
eliminated in a month after the end of therapy, and 22 ones - two 
months later 
Conclusion: The positive dinical effect and high percentage 
of C. trachomatis elimination were noticed during combined usage 
of antibiotic (sumamed) and IF inducer (cydoferon). Increase of 
IF-y induction shows normahtion of IF system and recovery of 
non-spec& resistance potential. IFS research allows to correct di- 
agnosis, to evaluate therapy efficacy, to predict the outcome of a 
disease. 
(AH). 
I P858b1 Interferon Status for Viral Hepatitis Outcome 
Prognosis 
R.Y. Arinenko, VB. Anikin, M.G. Romantsov. Influenza Rerearch 
Institute, St-Pefersbuq, Russia 
Objectives: Disease outcome prognosis with IF status (IFS) research. 
Methods: IFS that includes general serum IF (sIF) content and 
the evaluation of the induced production of IF-a/B and IF-y by 
leucocytes in vitro (induction of IF-aIB, - y )  was tested by bioassay. 
Chical observation was carried out with 19 acute viral hepatitis C 
patients. IFS research was performed before therapy, after Retrovir 
(AZT) course and 3 months later. 
Results: All treated patients grouped; gr. 1 with positive clinical 
dynamics (8) and gr. 2 without that (11); IFS of gr. 1 before treat- 
ment was characterised with increased sIF (up to 31.0 f 3.6 IU/ml) 
and decreased IF-a/B, -y induction (27.6 f 4.2% and 16.1 f 2.0% 
of normal values respectively). IFS improvement was ascertained af- 
ter therapy finished and in 3 months: decrease of sIF (to 22.5 f 
2.7 I U / d  and 21.3 f 1.8 IU/ml), increase ofinduction of IF-a/B 
(to 37.1 f 4.8% and 43.8 f 8.6%) and IF-y (to 27.0 f 6.2% and 
39.1 f 6.2%). In gr. 2 the sigdcant changes of IFS were not noted 
(before, after, in 3 months): 23.0 f 4.9, 19.3 f 2.6 u 18.3 f 3.5 
IU/ml for sIF; 39.7 f 4.8, 34.2 f 2.6, 42.0 f 6.4% for IFa/,S; 
54.8 f 6.7, 49.8 f 4.7 24.1 f 6.7 for IF-y. 
Conclusions: The group with promoted outcome (1) had ini- 
tially higher sIF that corresponds to lower IF-a/,S, -y induction 
values. Further sIF was decreasing and IF-a/,S, -y induction was 
recovering. In gr. 2 (with initially lowered IF system activity) the 
depression of IF-a/B, -y induction progressed that correlated with 
pathology aggravating. Doing research of IF status, we’ve got the 
complementary instrument for choice of treatment way, therapy ef- 
ficacy evaluation and the possible cksease outcome prognosis. 
IFNa-Induced Antiviral MxA Protein in Patients 
with Vial  Diseases 
V Chieux I ,  D. Hober ’, J. Harvey ’, G. Lion ’, L. Bocket I ,  
P. Watt& I .  ’Laboratoire de Virologie, CHU 59037 Lille, France, ‘Ciba 
Corning Diagnosticc COT.., Alameda, Ca,  USA, 3Hdpital de 
klenciennes, France 
Objectives: We studied the levels of the intracellular IFNU-induced 
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antiviral MxA protein in patients with viral dseases and in clinically 
stable patients with HIV-1 mfection grouped according to the 1993 
classification of the CDC. 
Methods: The quantification of MXA protein was performed in 
whole blood lysates by an immuno-chimiluminescent assay (Ciba 
Corning Diag. Corp.). 
Results: The mean f SD levels of MxA were 7 f 7 n g / d  in 
30 healthy volunteers and 12 f 8 ng/ml in 15 patients with various 
bacterial infections (p > 0.1 vs controls). The levels ofMxA protein 
were signhcantly hgher in blood cells of patients with various viral 
dections (53 & 79 ng/ml, p = 0.001, n = 27). Increased levels of 
MxA protein were found in patients with HIV-1 infection; however, 
a large range of values were obtained m each group of patients; 2 
to 149 n g / d  in group A (37 f 45, p < 0.001, n = lo), 1 to 185 
n g / d  in group B (22 f 40, p = 0.02, n = 21) and 4 to 180 n g / d  
in group C (35 i 51, p = 0.002, n = 7). The variations of MxA in 
each group were not associated with the number of CD4 T cells in 
peripheral blood. We found no correlation between the MxA levels 
and the log HIV-1 RNA copy number in plasma (Amplicor, Roche) 
in 39 HIV-1 positive patients. In IFN cr-untreated HCV+ patients 
the MxA levels were not sigrufcantly merent than the controls (p 
> 0.1, n = 8). In IFN a-treated HCV+ patients the MxA levels 
were higher than those of controls (126.7 f 64.7ng/ml, p c 0.001, 
n = 5). 
Conclusion: Our results showed that the quantitation of MxA 
protein may be useful for the dagnosis of the viral diseases and the 
follow up of the IFNa-treatment of VHC+ patients. 
I P860 1 Monitorization of Interferon-a Treatment in 
Patients with Chronic Hepatitis C 
F. Galin, M.T. Perez-Gracia, J. Perez-Moreno, M. Puertas, 
M.A. Rodriguez.-Iglesias. Lab. Microbiology and Digestive Unit. Puerto 
Real Uniu Hosp, University .f Cbdiz, Spain 
Objective: Chronic hepatitis C virus (HCV) infection is a progres- 
sive disease that can lead to cirrhosis. Interferon- (IFN-) trials in 
patients with chronic hepatitis C reported the efficacy of the therapy 
by meam of serum ALT levels and the improvement of liver histo- 
logical findings. Currently we have a controlled trial in patients with 
chronic HCV mfection. 
Methods: In the monitorization of the evolution has been em- 
ployed biochemical markers, pathological findings (Knodell index), 
quantitative determination of HCV antibodies to synthetic pep- 
tides (Innolia, Innogenetics); detection of HCV RNA viremia by 
RT-PCR assay (Amplicor) and determination of genotypes by lineal 
probe assay (Innolipa, Innogenetics). 
Results: At this moment, 43 patients have completed the treat- 
ment. After six months of therapy end, 10 patients (23.2%) show 
a complete remission in biochemical and pathological parameters, 
although one patient had HCV viremia at the end of the treatment. 
Four patients had an incomplete response. Twenty-nine patients were 
non responders; of them, 10 were maintaned in reinduction. At the 
end of the retreatment six of them showed a complete remission 
and four an incomplete response. Genotypes were determined in 29 
patients: 23 patients were identified as being infected with type lb, 
2 patients with type la, 2 patients with type 3a, and one with type 
4. In one case, it was detected a coinfection la + lb. 
Conclusions: We found that detection of serum HCV RNA is 
the best technique to predict the f inal  outcome of HCV-infected 
patients after IFN therapy, because we have found a correlation be- 
tween HCV RNA viremia and clinical evolution during follow-up. 
Epidemiology of bacteremia and of 
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I P861 I Computer-Assisted Infection Monitoring (CAI) in 
ICU 
A. Heininger *, A. Niemetz ', R. Fretschner 
&r Amesfhesiologie det Univetsitiit Tiibingen, Germany, 'Niemetz 
GesmbH, A4616 Wegkirchen, Germany 
Objectives: Diagnosis and therapy of nosocomial infections require 
an efficacious management of a great amount of data. In the past 
decade, computerized surveillance system (l), h g  decisions au- 
tomatically, were developed. 
Methods: CAI is an interactive program delivering data fiom 
clinical monitoring, microbiologic cultures and laboratory values. 
CAI asks the physician to evaluate the relevance of the data ac- 
cording to the Criteria of CDC (2). Thus dugnosis and therapy 
are defined by the physician but not automatically generated by the 
computer program itself. In a third step CAI double-checks the de- 
cision given by the physician with the available data. Is there any 
mistake, alerts are automatically generated. In addition the program 
indicates the kind of antibiotic treatment (empiric, calculated, spe- 
cific or prophylactic). 
Connecting clinical and microbiologic data with medical deci- 
sions CAI allows an evaluation of epidemiologic data with regard to 
prescribing patterns and cost development. 
Discussion: CAI may contribute to standardization of diagnos- 
tic and therapeutic procedures in nosocomial infection. It facilitates 
diagnosis and treatment but doesn't renounce the speclfic medical 
decision. This is an important advantage of CAI compared with 
former infection surveillance systems. 
K. Unertl 'Klinik 
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lp8621 Doctors are Falsely Comforted by Unvalidated 
Data on lnfeaion Rates - Practical Suggestions 
on What to Do 
K.B. Poulsen, M. Meyer. T h e  National Centerfor Hospital Hygiene, 
Statens Serum Insitut, Copenhagen, Denmark 
Objectives: To validate routine s u r v e h c e  of surgical wound in- 
fections. To test methods on how to improve the relevance, simplic- 
ity and quality of registration. 
Methods: Two consecutive bedside prevalence surveys were made 
by the same infection control nurse in 15 merent surgical and gy- 
naecological departments. The results were compared to the elec- 
tronic routine incidence surveillance system of the hospital. 
To improve the clinical relevance of the surveillance in eight 
surgtcal departments other complications were included. DiEerent 
methods of registration, such as only prevalence surveys, selective 
registration, follow up after discharge, and optimizing the use of 
administrative systems are tested. 
Results: The prevalence survey showed that 4.6% of the pa- 
tients had a deep surgical wound mfection and additional 4.6% had 
a surperficial mfection. However only one third of these infections 
were recorded in the hospital routine surveillance system. P r e h -  
nary results indicate that hospital acquired infections makes up only 
a s d  hction of even serious complications to tradihond surgical 
treatments. 
Conclusions: Registrations needs to be validated before compar- 
isons. Clinical guidance based on unvalidated data can be serously 
